<SEC-DOCUMENT>0001279569-18-002463.txt : 20181213
<SEC-HEADER>0001279569-18-002463.hdr.sgml : 20181213
<ACCEPTANCE-DATETIME>20181213085014
ACCESSION NUMBER:		0001279569-18-002463
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181213
FILED AS OF DATE:		20181213
DATE AS OF CHANGE:		20181213

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Canopy Growth Corp
		CENTRAL INDEX KEY:			0001737927
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38496
		FILM NUMBER:		181232248

	BUSINESS ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
		BUSINESS PHONE:		855-558-9333

	MAIL ADDRESS:	
		STREET 1:		1 HERSHEY DRIVE
		CITY:			SMITH FALLS
		STATE:			A6
		ZIP:			K7A0A8
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>canopy6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 3pt">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"></p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 12pt; margin-bottom: 3pt"><div style="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 4pt 0 0; text-align: center"><b>UNITED STATES </b></p>

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549 </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 18pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>FORM&nbsp;6-K </b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>REPORT OF FOREIGN ISSUER </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>PURSUANT TO RULE 13a-16 OR 15d-16
</b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>OF THE SECURITIES EXCHANGE ACT OF
1934 </b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>For the month of December 2018
</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Commission File No.&nbsp;001-38496</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 24pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>Canopy Growth Corporation</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>1 Hershey Drive<br>
Smith Falls, Ontario<br>
K7A 0A8</b></p>

<p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<!-- Field: Rule-Page --><div align="left" style="margin: 1pt 1.7in"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files
or will file annual reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Form&nbsp;20-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font>
<font style="font-family: Times New Roman, Times, Serif">Form 40-F&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(1):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting
the Form&nbsp;6-K in paper as permitted by Regulation S-T Rule&nbsp;101&nbsp;(b)&nbsp;(7):</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant by furnishing
the information contained in this Form&nbsp;is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b)&nbsp;under
the Securities Exchange Act of 1934.</p>

<p style="font: 10pt/normal Calibri, Helvetica, Sans-Serif; margin: 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;Yes&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9744;</font><font style="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;&nbsp;&nbsp;No&nbsp;&nbsp;</font><font style="font-family: Segoe UI Symbol,sans-serif">&#9746;</font>
<font style="font-family: Times New Roman, Times, Serif">&nbsp;</font></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0 0 8pt">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Rule-Page --><div align="left" style="margin-top: 3pt; margin-bottom: 12pt"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>EXHIBIT INDEX </b></p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 8%">&nbsp;</td>
    <td style="width: 2%">&nbsp;</td>
    <td style="width: 90%">&nbsp;</td></tr>
<tr>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: bottom">
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Exhibit</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td>
    <td>&nbsp;</td>
    <td nowrap>
        <p style="font: 8pt/normal Times New Roman, Times, Serif; margin: 0"><b>Description</b></p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr style="vertical-align: top">
    <td nowrap style="font: 11pt/107% Calibri, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">99.1</A></FONT></td>
    <td><FONT STYLE="color: Black">&nbsp;</FONT></td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><A HREF="ex991.htm">Press
    Release - Canopy Growth announces multi-year extraction agreement with Valens GroWorks</A></FONT></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">1</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"></DIV>
    <!-- Field: /Page -->

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">&nbsp;</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;&nbsp;</p>

<p style="font: 12pt/normal Times New Roman, Times, Serif; margin: 0"><u></u></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
<tr>
    <td style="width: 50%">&nbsp;</td>
    <td style="width: 7%">&nbsp;</td>
    <td style="width: 43%">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Canopy Growth Corporation</font></td></tr>
<tr style="vertical-align: top">
    <td>&nbsp;</td>
    <td colspan="2" style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td>
    <td style="font: 11pt/107% Calibri, Helvetica, Sans-Serif">&nbsp;</td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="vertical-align: bottom">
        <p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">/s/ Bruce Linton</p>
<!-- Field: Rule-Page --><div align="left" style="margin-top: 1pt; margin-bottom: 1pt"><div style="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</div></div><!-- Field: /Rule-Page --></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bruce Linton</font></td></tr>
<tr>
    <td>&nbsp;</td>
    <td style="vertical-align: top; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="vertical-align: bottom; font: 11pt/107% Calibri, Helvetica, Sans-Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</font></td></tr>
</table>
<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0">Date: December 13, 2018 </p>

<p style="font: 1pt/normal Times New Roman, Times, Serif; margin: 0.25in 0 0"></p>

<p style="font: 10pt/normal Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">2</p>




<p style="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED DECEMBER 13, 2018
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><IMG SRC="image_001.jpg" ALT="Logo: Canopy Growth Corporation (CNW Group|Canopy Growth Corporation)" STYLE="height: 144px; width: 144px"></P>

<P STYLE="font: bold 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Canopy Growth announces multi-year extraction
agreement with Valens GroWorks</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SMITHS FALLS, ON, Dec. 13, 2018 /CNW/ -<B>&nbsp;</B>Canopy
Growth Corporation (TSX: WEED) (NYSE: CGC) (&quot;Canopy Growth&quot; or the &quot;Company&quot;) announces today that it has entered
into a multi-year extraction agreement with Valens GroWorks Corp. (CSE: VGW) (OTC-PINK: MYMSF) (&quot;Valens&quot;), a licensed,
vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation,
cannabinoid isolation and purification.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Under the terms of the multi-year agreement,
Valens will utilize their proprietary technology and methodologies to process the Company's whole flower and trim into high-grade
cannabis resin. Canopy Growth expects the first shipment of product for extraction will occur before the end of December 2018.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Valens previously joined Canopy Growth's CraftGrow
program in October 2017. CraftGrow provides craft cannabis producers with the opportunity to bring unique cannabis products to
market through the Company's leading sales channels. Having recently received its cultivation licence, Valens expects to have its
first branded products available via CraftGrow for the medical and recreational markets by the end of March 2019.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;Diversifying our extraction supply capabilities
with Valens, a company positioning itself as a specialized extractor, increases our ability to supply a consistent, high-quality
inventory of oils for products such as Softgels,&quot; commented Mark Zekulin, President &amp; Co-CEO, Canopy Growth. &quot;We're
also excited to see Valens progress in its licensing capabilities so that it can add its products to our CraftGrow program, increasing
the diversity of high-quality cannabis products available for medical and recreational customers in 2019.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;We are pleased to provide specialized
extraction services to support Canopy Growth's innovative product offerings, while also capitalizing on our CraftGrow partnership
to bring Valens branded products to market in the new year,&quot; says Tyler Robson, CEO, Valens GroWorks Corp. &quot;We take pride
in our proprietary extraction processes and are honoured to be recognized for our capabilities in supporting the growth of the
cannabis market, particularly with the increasing role cannabis oils will soon play in the edibles space.&quot;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Here's to Future Growth.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Canopy Growth Corporation</B><BR>
Canopy Growth is a world-leading diversified cannabis and hemp company, offering distinct brands and curated cannabis varieties
in dried, oil and Softgel capsule forms. From product and process innovation to market execution, Canopy Growth is driven by a
passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. The
Company has operations in 12 countries across five continents. The Company is proudly dedicated to educating healthcare practitioners,
conducting robust clinical research, and furthering the public's understanding of cannabis, and through its partly owned subsidiary,
Canopy Health Innovations, has devoted millions of dollars toward cutting edge, commercializable research and IP development. Through
partly owned subsidiary Canopy Rivers Corporation, the Company is providing resources and investment to new market entrants and
building a portfolio of stable investments in the sector. From our historic public listing on the Toronto Stock Exchange and New
York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained
in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icon Snoop
Dogg, breeding legends DNA Genetics and Green House seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few.
Canopy Growth operates ten licensed cannabis production sites with over 4.3 million square feet of production capacity, including
over 500,000 square feet of GMP certified production space. For more information visit www.canopygrowth.com</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Valens GroWorks</B><BR>
Valens GroWorks Corp. is a research-driven, vertically integrated Canadian cannabis company focused on downstream secondary extraction
methodology, distillation and cannabinoid isolation and purification, as well as associated quality testing with three wholly-owned
subsidiaries located in and around Kelowna, BC. Subsidiary Valens Agritech (&quot;VAL&quot;) holds a license to cultivate cannabis
and produce cannabis oil under the Cannabis Act, as well as a license to conduct analytical testing for the cannabis industry.&nbsp;
VAL also has a supply agreement with Canopy Growth Corporation under their extensive CraftGrow distribution network. Subsidiary
Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services
and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science. Subsidiary Valens Farms
is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP)
standards, ensuring the product from this facility can be exported anywhere in the world where Cannabis is nationally legal for
medical or adult usage purposes. For more information, please visit http://valensgroworks.com. The Company's investor deck can
be found specifically at http://valensgroworks.com/investors/</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Notice Regarding Forward Looking Statements</B><BR>
This news release contains &quot;forward-looking statements&quot; within the meaning of the United States Private Securities Litigation
Reform Act of 1995 and &quot;forward-looking information&quot; within the meaning of applicable Canadian securities legislation.
Often, but not always, forward-looking statements and information can be identified by the use of words such as &quot;plans&quot;,
&quot;expects&quot; or &quot;does not expect&quot;, &quot;is expected&quot;, &quot;estimates&quot;, &quot;intends&quot;, &quot;anticipates&quot;
or &quot;does not anticipate&quot;, or &quot;believes&quot;, or variations of such words and phrases or state that certain actions,
events or results &quot;may&quot;, &quot;could&quot;, &quot;would&quot;, &quot;might&quot; or &quot;will&quot; be taken, occur
or be achieved. Forward-looking statements or information involve known and unknown risks, uncertainties and other factors which
may cause the actual results, performance or achievements of Canopy Growth or its subsidiaries to be materially different from
any future results, performance or achievements expressed or implied by the forward-looking statements or information contained
in this news release. Examples of such statements include statements with respect to new products entering Canopy Growth sales
channels, and statements regarding extracted product and supply into medical or recreational markets. Risks, uncertainties and
other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities
to differ materially from those expressed or implied by such forward-looking information, and such risks contained in the Company's
annual information form dated June 27, 2018 and filed with Canadian securities regulators available on the Company's issuer profile
on SEDAR at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking
information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information
and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information
and forward-looking statements included in this news release are made as of the date of this news release and the Company does
not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information,
subsequent events or otherwise unless required by applicable securities laws.</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/December2018/13/c4072.html</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001737927</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>Caitlin O'Hara, Media Relations,
Caitlin.Ohara@canopygrowth.com, 613-291-3239; Investor Relations: Tyler Burns, Tyler.Burns@canopygrowth.com, 855-558-9333 ext.
122; Director: Bruce Linton, tmx@canopygrowth.com</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Canopy Growth Corporation</P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 08:30e 13-DEC-18</P>



<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><FONT STYLE="font-size: 12pt"></FONT></P>



<P STYLE="font: bold 14pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[0'@4&AO=&]S:&]P(#,N,  X0DE-! 0
M     <0< G@ 14QO9V\Z($-A;F]P>2!'<F]W=&@@0V]R<&]R871I;VX@*$-.
M5R!'<F]U<"]#86YO<'D@1W)O=W1H($-O<G!O<F%T:6]N*1P"6@ ,4TU)5$A3
M($9!3$Q3' )T   < F4  !P"4  (2&%N9"UO=70< E\  D].' (9 $!#86YO
M<'D@1W)O=W1H($-O<G!O<F%T:6]N.T5C;VYO;6EC(&YE=W,[('1R96YD<SL@
M86YA;'ES:7,[36%T=7)E' )I $!#86YO<'D@1W)O=W1H($-O<G!O<F%T:6]N
M+4-A;F]P>2!'<F]W=&@@0V]R<&]R871I;VX@86YN;W5N8V5S(&9I' (% $!#
M86YO<'D@1W)O=W1H($-O<G!O<F%T:6]N+4-A;F]P>2!'<F]W=&@@0V]R<&]R
M871I;VX@86YN;W5N8V5S(&9I' )S  -#3E<< C< "#(P,3@Q,C V' )N !E#
M86YO<'D@1W)O=W1H($-O<G!O<F%T:6]N' )G   < GH  D-.' (H !%3964@
M4F5L96%S92!#-C0V,1P"%  35V5B<VET941I<W1R:6)U=&EO;AP"#P #2$5!
M' (   ( !/_; $, ! (# P,"! ,# P0$! 0%"08%!04%"P@(!@D-"PT-#0L,
M# X0%!$.#Q,/# P2&!(3%187%Q<.$1D;&18:%!87%O_; $,!! 0$!04%"@8&
M"A8/# \6%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%O_  !$( )  D ,!(@ "$0$#$0'_Q  <  $  @,! 0$
M        !@<$!0@# 0+_Q  U$  ! P,$ 0,# @0%!0     ! @,$  41!@<2
M(3$305$(%"(5,B-A<8$6)#-2D0D8)4*2_\0 &@$!  (# 0
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MY)RL_K_3;]SPFE$YTM4"/#MAO35QMQ,7(5&D+')_"NEH3G./CWRGW[K]6O\
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MUH>7$?\ T*_22% %)!!\$53[FI_II2@E3^WP 6\A68L?(4R 7@1QZ],$%?\
MMR,XJ2V_=;:>%IN1)AZQT_&M5F0PB0IJ0E#,)#B26>6,!"%)22DG ('561SD
M\I45F;DZ%B3K3"E:HMS,F_(#EK96[A<U)\%I.,J_MX'9ZJ5 Y&: 51GU#7"/
M8?J6VLU'JIY$;2,1-TCF;(/&+!NCK3:8RWE'\4%3?KH0I6 %*(R":O.O"=#B
M38CL69&:D,/)XNM.H"T+'P4GHC^M 5-N-K;1\"-?7=&W*U#5.H50[+'N*9"4
MM/S'/40P@O#(4ME"G'5!(*DHXY\I!A>Q=TMNV6MMR-HKO-L]GCL1O\36.,W<
MO4;CQI#2D2&@M:4$%#[2G""D8#^?'==",V*R,PF(;5H@(CQ?]!E,5 0UWG\4
M@83W\5HK[/L[=VD-2=%W&:XE6%R&[.EU+O0["S^[KK^U <W:?BN;<Z0TM_A\
M)N6W>Y+ME4E$3#K5BO1>C*4I.#A,>24*SCI#P]N=63L?<[=IO=#>&-KJXQ+?
M=G]3_J8=N#R6A(M!BLHC+2I> II 0Z@X)"5!0.">Y],U;:8%N2TO1.HQ&"P4
MM,V%2TA7+D#P3G'Y './/\ZC-QW>VXN\IH3M,WV<]%>XM>OI=YU33GG\>2#Q
M/@]?&:A*R$=TFD249/@BB[9^HV/9#8R-(?CVQ;NYSLRR1;JLM_;VU?Z@J-S0
M2%! :6W@=<0I Z\5:>X>T<&U[%Z]N-XU"VU?+K=7-7MW:,T(S5KN3+2#'7'2
MI1XA/H(22I1*^:\_NP-S<-^=J9;O^>MUV?6V"G^/IYU:D@]X[3U[5[2/J!VS
MFPG&GXE\D1P 7$KL#RT8R,9!3CSC^]:_%:?G75$NZLY7T-O]+SK=YV>M.MI$
MQB;=M7Q6+Q=I3!'$ONM(/I)[/%#2>+24DY 1WV35/;;:M;T)]'NM47R/:)FK
M]/3+U)U=9KT_Z:[DXM]YPE0_<L/L*:#:L*2I. ,XZLF#]0&V,6*6H<.]LL@E
M12S8'DI!/DX"<5C7#>[:.?)9N4VRW.2\P>+,E_33BU-X[PE:D$C'GHT\5I^=
M=4.YMY7T(QJ6X7:7]4VW3-HO&G[/?'MN[D$HDL+D,,N..PE(;#7JMK/CK)R0
MD]'VA&S\VTQ+%]/UW),32]EN%\AWL2I27&[;?' ZAM3YXI#?)TR@WE*0GUD
M8R,W"YOWM.[,3-<@W1<@$%+RM/.E>1X(5QSU[5Z'?#:K[=YM^VW1IBXA3CWJ
MZ=>X2O\ U)4.'Y^,$G/C^5/%4<ZZH=U9ROH:1ZSP-;_5MJF/;^$O3<O;H634
M[T=04R]*=DK++2E#I3J&%/$^2E+B0<<A5/634NKK3HS16Z%W8GN#9&X#1U[C
MH:RNX<UKA3' /*P.-N4GVY>I[BNA+5O;M;;X;<2VQ;G%CI44MM1]/OMH!/9P
ME* .ZW-DW!TE>D2XEMT]>I24.!R6T+ Z '%$*RM*DC\B0#WWD=]U*%]4WB,D
M_P!D7"<>*(GN9I:W:8^D[4EPOJ8R+^SHF[,RIKK@!,B6RM^2E))Q^;^/YGBD
M5$-\6=.I_P"G?>=21W(7WEQV\A0')B'D_P <-L@MM9S@E*G'<#S^1%79<M7V
MR0T6)ND]22$9"N"]/O.)R.P?VD9J01(%KE6=AL6MA$90#R([L5*0VH]]H(_%
M79SUG.:VD2A]8W"2S]2&R#M[U58YK3RKLN.8L?[?I=MXI.2\X%A1Z& ,GY\5
MT0.Q6"JS6A1:)M<(EA(2T3'1_# .0$]= 'L8K.  &!0"E*4 KY@? K[2@/.2
MRV]'6RL'BXDI5@X.",>:K:^;97!V3%C6_4LUNW)RF47'EB6M/E*0\DC(!)_<
M#Y]QU5FTP*T7:>NY8FB<+)0?E90FK]G&G-3Z=M]NA2U0F(_^=6"D(;PO)5ZA
M Y+7R/D9_ ?-9VG-NM-ZDW$N;4^RMIAV!L0Y00\L"?*40L+)SGBELHPD^"K'
M>,U:FI]26&PO,-W:XLQG9'32%94I7R>(!.![GQ4"T5J[3]AU/K*1>+FW"BS+
MRE^*[(;6A+P^W;!*"1^6"D^/BJJ>BTE5JSC#>_./1'0K[I1X\#7[T[3Z>C:$
MN-WM8>C2+=$<?7AS/W*4)/%"CCPD>/Z#/S6!M'LG&3;(5ROTY,I#H9ELL1R?
M34%)"N+B5 I5W@=#L#O^4CU=N;HS4.WE[BPISSKLBW/-ML&(Z%N%2.*,#C[E
M22/D=U[;=;CZ0M^B+!;[E>&XTA%MC-.!X%/%S'#B?@@H.<] 8^16IZ;03U*E
MNQC]<27>7JK9W\2$:=VU8LLK46IKU;I3\" IY:!*6&E3&4**EJXC!22D''@'
MQCOJ7[3[96'_  M%NUQMOI3YR%OMAMU7^38=*E)CH!. D(7@CW))K/W"UEI2
M^[?ZAM=IO3$R0[;'T)3%2IWDHMG"04@@J\=>1D9K;[?:JLLK3MI@+N3"+A]D
MPA<99*%^IZ8RD)5@DY!_XK=1I-)"U1CAK'\<6R-EMLH9>XC+^S%H$Z2F&^Y'
MA.LJ0PCR8N0!P0/]F>SWGLCWR+%L%IA6F"W'AQFF@EM*5%* "L@ 94?)/7D]
MUGXZI5G3I::6W".#GG9.:\S/F!\#_BOM*5T$!2E* 4I2@%*4H!2E* AUMW!T
M_.O*V@B4U&;G/V]NYO1^$5Z0PE1>0APG.$<' 5D!!4A20HD8J2S(MOND9 ?9
MCRVB.2.:$N)(*2,C.1VDD?T-0_5FW,23%CBUA):C7I%W5:Y4AS[*0Z"XL@I
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)%*4H!2E* __9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
